Virtus ETF Advisers LLC Harmony Biosciences Holdings, Inc. Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 10,975 shares of HRMY stock, worth $370,296. This represents 0.16% of its overall portfolio holdings.
Number of Shares
10,975
Previous 11,067
0.83%
Holding current value
$370,296
Previous $442,000
14.71%
% of portfolio
0.16%
Previous 0.21%
Shares
15 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$223 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$160 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$76.9 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$53.3 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...